| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.988 | 0.001 | 0.988 | Opioid mu receptor antagonist | 0.87 0.001 DBMET00342 0.946 0.001 DBMET00424 0.825 0.002 DBMET00425 0.825 0.002 DBMET00426 0.988 0.001 DBMET00321 0.948 0.001 DBMET00427 0.874 0.001 DBMET00428 0.874 0.001 DBMET00429 | ||
| 0.989 | 0.003 | 0.99 | Analgesic | 0.983 0.003 DBMET00342 0.99 0.003 DBMET00424 0.977 0.004 DBMET00425 0.977 0.004 DBMET00426 0.989 0.003 DBMET00321 0.985 0.003 DBMET00427 0.974 0.004 DBMET00428 0.974 0.004 DBMET00429 | DBMET00424 | |
| 0.985 | 0.001 | 0.985 | Opioid antagonist | 0.891 0.001 DBMET00342 0.951 0.001 DBMET00424 0.853 0.002 DBMET00425 0.853 0.002 DBMET00426 0.985 0.001 DBMET00321 0.948 0.001 DBMET00427 0.889 0.001 DBMET00428 0.889 0.001 DBMET00429 | ||
| 0.984 | 0.001 | 0.987 | Analgesic, opioid | 0.961 0.001 DBMET00342 0.987 0.001 DBMET00424 0.933 0.002 DBMET00425 0.933 0.002 DBMET00426 0.984 0.001 DBMET00321 0.966 0.001 DBMET00427 0.929 0.002 DBMET00428 0.929 0.002 DBMET00429 | DBMET00424 | |
| 0.972 | 0.001 | 0.972 | Opioid delta receptor antagonist | 0.843 0.001 DBMET00342 0.916 0.001 DBMET00424 0.788 0.002 DBMET00425 0.788 0.002 DBMET00426 0.972 0.001 DBMET00321 0.909 0.001 DBMET00427 0.838 0.001 DBMET00428 0.838 0.001 DBMET00429 | ||
| 0.958 | 0.001 | 0.958 | Opioid kappa receptor antagonist | 0.807 0.001 DBMET00342 0.887 0.001 DBMET00424 0.768 0.001 DBMET00425 0.768 0.001 DBMET00426 0.958 0.001 DBMET00321 0.888 0.001 DBMET00427 0.81 0.001 DBMET00428 0.81 0.001 DBMET00429 | ||
| 0.954 | 0.001 | 0.955 | Opioid agonist | 0.933 0.001 DBMET00342 0.955 0.001 DBMET00424 0.887 0.001 DBMET00425 0.887 0.001 DBMET00426 0.954 0.001 DBMET00321 0.934 0.001 DBMET00427 0.886 0.002 DBMET00428 0.886 0.002 DBMET00429 | DBMET00424 | |
| 0.931 | 0.001 | 0.931 | Opioid mu receptor agonist | 0.891 0.001 DBMET00342 0.924 0.001 DBMET00424 0.801 0.001 DBMET00425 0.801 0.001 DBMET00426 0.931 0.001 DBMET00321 0.905 0.001 DBMET00427 0.844 0.001 DBMET00428 0.844 0.001 DBMET00429 | ||
| 0.93 | 0.001 | 0.954 | Opioid delta receptor agonist | 0.895 0.001 DBMET00342 0.954 0.001 DBMET00424 0.801 0.002 DBMET00425 0.801 0.002 DBMET00426 0.93 0.001 DBMET00321 0.836 0.001 DBMET00427 0.759 0.002 DBMET00428 0.759 0.002 DBMET00429 | DBMET00424 | |
| 0.843 | 0.002 | 0.853 | Antipruritic | 0.707 0.003 DBMET00342 0.756 0.003 DBMET00424 0.719 0.003 DBMET00425 0.719 0.003 DBMET00426 0.843 0.002 DBMET00321 0.853 0.002 DBMET00427 0.819 0.002 DBMET00428 0.819 0.002 DBMET00429 | DBMET00427 | |
| 0.839 | 0.003 | 0.839 | Sigma receptor antagonist | 0.67 0.004 DBMET00342 0.752 0.003 DBMET00424 0.529 0.004 DBMET00425 0.529 0.004 DBMET00426 0.839 0.003 DBMET00321 0.766 0.003 DBMET00427 0.697 0.004 DBMET00428 0.697 0.004 DBMET00429 | ||
| 0.814 | 0.001 | 0.814 | Opioid kappa receptor agonist | 0.666 0.001 DBMET00342 0.733 0.001 DBMET00424 0.603 0.001 DBMET00425 0.603 0.001 DBMET00426 0.814 0.001 DBMET00321 0.759 0.001 DBMET00427 0.687 0.001 DBMET00428 0.687 0.001 DBMET00429 | ||
| 0.777 | 0.004 | 0.777 | Psychostimulant | 0.685 0.004 DBMET00342 0.687 0.004 DBMET00424 0.534 0.009 DBMET00425 0.534 0.009 DBMET00426 0.777 0.004 DBMET00321 0.613 0.005 DBMET00427 0.611 0.005 DBMET00428 0.611 0.005 DBMET00429 | ||
| 0.752 | 0.002 | 0.752 | Toll-Like receptor antagonist | 0.54 0.003 DBMET00342 0.561 0.003 DBMET00424 0.359 0.005 DBMET00425 0.359 0.005 DBMET00426 0.752 0.002 DBMET00321 0.534 0.003 DBMET00427 0.515 0.003 DBMET00428 0.515 0.003 DBMET00429 | ||
| 0.666 | 0.001 | 0.666 | Toll-Like receptor 4 antagonist | 0.581 0.001 DBMET00342 0.625 0.001 DBMET00424 0.463 0.002 DBMET00425 0.463 0.002 DBMET00426 0.666 0.001 DBMET00321 0.516 0.001 DBMET00427 0.493 0.002 DBMET00428 0.493 0.002 DBMET00429 | ||
| 0.679 | 0.023 | 0.679 | Transcription factor NF kappa B inhibitor | 0.617 0.029 DBMET00342 0.615 0.029 DBMET00424 0.56 0.036 DBMET00425 0.56 0.036 DBMET00426 0.679 0.023 DBMET00321 0.623 0.028 DBMET00427 0.625 0.028 DBMET00428 0.625 0.028 DBMET00429 | ||
| 0.597 | 0.003 | 0.597 | Acetylcholine M1 receptor antagonist | 0.276 0.019 DBMET00342 0.365 0.008 DBMET00424 0.274 0.02 DBMET00425 0.274 0.02 DBMET00426 0.597 0.003 DBMET00321 0.594 0.003 DBMET00427 0.465 0.004 DBMET00428 0.465 0.004 DBMET00429 | ||
| 0.598 | 0.005 | 0.627 | Anesthetic general | 0.491 0.008 DBMET00342 0.51 0.007 DBMET00424 0.519 0.007 DBMET00425 0.519 0.007 DBMET00426 0.598 0.005 DBMET00321 0.627 0.004 DBMET00427 0.607 0.004 DBMET00428 0.607 0.004 DBMET00429 | DBMET00427 | |
| 0.556 | 0.017 | 0.802 | Spasmolytic | 0.33 0.059 DBMET00342 0.35 0.052 DBMET00424 0.619 0.011 DBMET00425 0.619 0.011 DBMET00426 0.556 0.017 DBMET00321 0.802 0.004 DBMET00427 0.783 0.004 DBMET00428 0.783 0.004 DBMET00429 | DBMET00427 | |
| 0.467 | 0.013 | 0.505 | Sigma receptor agonist | 0.161 0.078 DBMET00342 0.136 0.096 DBMET00424 0.223 0.055 DBMET00425 0.223 0.055 DBMET00426 0.467 0.013 DBMET00321 0.5 0.009 DBMET00427 0.505 0.009 DBMET00428 0.505 0.009 DBMET00429 | DBMET00429 | |
| 0.427 | 0.041 | 0.48 | 5 Hydroxytryptamine release stimulant | 0.313 0.066 DBMET00342 0.323 0.063 DBMET00424 0.375 0.051 DBMET00425 0.375 0.051 DBMET00426 0.427 0.041 DBMET00321 0.48 0.031 DBMET00427 0.472 0.032 DBMET00428 0.472 0.032 DBMET00429 | DBMET00427 | |
| 0.373 | 0.005 | 0.488 | Breast cancer-resistant protein inhibitor | 0.488 0.005 DBMET00342 0.432 0.005 DBMET00424 0.413 0.005 DBMET00425 0.413 0.005 DBMET00426 0.373 0.005 DBMET00321 0.31 0.007 DBMET00427 0.361 0.005 DBMET00428 0.361 0.005 DBMET00429 | DBMET00342 | |
| 0.37 | 0.005 | 0.37 | Toll-Like receptor 9 antagonist | 0.24 0.023 DBMET00342 0.285 0.015 DBMET00424 0.37 0.005 DBMET00321 0.183 0.043 DBMET00427 0.153 0.061 DBMET00428 0.153 0.061 DBMET00429 | ||
| 0.343 | 0.005 | 0.442 | Cyclooxygenase 3 inhibitor | 0.442 0.004 DBMET00342 0.352 0.005 DBMET00424 0.368 0.004 DBMET00425 0.368 0.004 DBMET00426 0.343 0.005 DBMET00321 0.283 0.007 DBMET00427 0.359 0.005 DBMET00428 0.359 0.005 DBMET00429 | DBMET00342 | |
| 0.341 | 0.011 | 0.354 | Cholinergic antagonist | 0.16 0.047 DBMET00342 0.193 0.034 DBMET00424 0.167 0.044 DBMET00425 0.167 0.044 DBMET00426 0.341 0.011 DBMET00321 0.354 0.01 DBMET00427 0.294 0.015 DBMET00428 0.294 0.015 DBMET00429 | DBMET00427 | |
| 0.394 | 0.066 | 0.593 | Immunosuppressant | 0.544 0.022 DBMET00342 0.566 0.018 DBMET00424 0.593 0.014 DBMET00425 0.593 0.014 DBMET00426 0.394 0.066 DBMET00321 0.481 0.038 DBMET00427 0.455 0.046 DBMET00428 0.455 0.046 DBMET00429 | DBMET00426 | |
| 0.347 | 0.021 | 0.361 | P-glycoprotein inhibitor | 0.332 0.024 DBMET00342 0.268 0.036 DBMET00424 0.282 0.033 DBMET00425 0.282 0.033 DBMET00426 0.347 0.021 DBMET00321 0.293 0.03 DBMET00427 0.361 0.02 DBMET00428 0.361 0.02 DBMET00429 | DBMET00429 | |
| 0.334 | 0.011 | 0.346 | Acetylcholine antagonist | 0.156 0.047 DBMET00342 0.189 0.034 DBMET00424 0.162 0.044 DBMET00425 0.162 0.044 DBMET00426 0.334 0.011 DBMET00321 0.346 0.01 DBMET00427 0.285 0.015 DBMET00428 0.285 0.015 DBMET00429 | DBMET00427 | |
| 0.316 | 0.008 | 0.326 | Acetylcholine muscarinic antagonist | 0.13 0.058 DBMET00342 0.159 0.039 DBMET00424 0.135 0.054 DBMET00425 0.135 0.054 DBMET00426 0.316 0.008 DBMET00321 0.326 0.007 DBMET00427 0.267 0.012 DBMET00428 0.267 0.012 DBMET00429 | DBMET00427 | |
| 0.323 | 0.036 | 0.336 | Nitric oxide antagonist | 0.298 0.041 DBMET00342 0.3 0.04 DBMET00424 0.311 0.038 DBMET00425 0.311 0.038 DBMET00426 0.323 0.036 DBMET00321 0.336 0.034 DBMET00427 0.331 0.035 DBMET00428 0.331 0.035 DBMET00429 | DBMET00427 | |
| 0.282 | 0.022 | 0.392 | Cholinergic | 0.392 0.01 DBMET00342 0.362 0.012 DBMET00424 0.329 0.015 DBMET00425 0.329 0.015 DBMET00426 0.282 0.022 DBMET00321 0.229 0.035 DBMET00427 0.261 0.026 DBMET00428 0.261 0.026 DBMET00429 | DBMET00342 | |
| 0.259 | 0.024 | 0.278 | Protein kinase stimulant | 0.198 0.042 DBMET00342 0.197 0.043 DBMET00424 0.217 0.036 DBMET00425 0.217 0.036 DBMET00426 0.259 0.024 DBMET00321 0.278 0.02 DBMET00427 0.278 0.02 DBMET00428 0.278 0.02 DBMET00429 | DBMET00429 | |
| 0.232 | 0.004 | 0.233 | Nociceptin (N/OFQ) receptor antagonist | 0.122 0.005 DBMET00342 0.18 0.004 DBMET00424 0.125 0.005 DBMET00425 0.125 0.005 DBMET00426 0.232 0.004 DBMET00321 0.233 0.004 DBMET00427 0.174 0.004 DBMET00428 0.174 0.004 DBMET00429 | DBMET00427 | |
| 0.245 | 0.022 | 0.321 | Acetylcholinesterase inhibitor | 0.321 0.011 DBMET00342 0.289 0.014 DBMET00424 0.258 0.019 DBMET00425 0.258 0.019 DBMET00426 0.245 0.022 DBMET00321 0.181 0.039 DBMET00427 0.22 0.028 DBMET00428 0.22 0.028 DBMET00429 | DBMET00342 | |
| 0.292 | 0.069 | 0.365 | Hypoxia-inducible factor 1 alpha inhibitor | 0.18 0.179 DBMET00342 0.229 0.12 DBMET00425 0.229 0.12 DBMET00426 0.292 0.069 DBMET00321 0.36 0.042 DBMET00427 0.365 0.04 DBMET00428 0.365 0.04 DBMET00429 | DBMET00429 | |
| 0.222 | 0.009 | 0.224 | Antineoplastic alkaloid | 0.209 0.011 DBMET00342 0.212 0.01 DBMET00424 0.211 0.011 DBMET00425 0.211 0.011 DBMET00426 0.222 0.009 DBMET00321 0.224 0.008 DBMET00427 0.221 0.009 DBMET00428 0.221 0.009 DBMET00429 | DBMET00427 | |
| 0.27 | 0.064 | 0.323 | 5 Hydroxytryptamine uptake stimulant | 0.323 0.035 DBMET00342 0.294 0.048 DBMET00424 0.309 0.04 DBMET00425 0.309 0.04 DBMET00426 0.27 0.064 DBMET00321 0.259 0.073 DBMET00427 0.283 0.054 DBMET00428 0.283 0.054 DBMET00429 | DBMET00342 | |
| 0.23 | 0.05 | 0.318 | Hepatoprotectant | 0.206 0.061 DBMET00342 0.197 0.067 DBMET00424 0.294 0.031 DBMET00425 0.294 0.031 DBMET00426 0.23 0.05 DBMET00321 0.317 0.025 DBMET00427 0.318 0.025 DBMET00428 0.318 0.025 DBMET00429 | DBMET00429 | |
| 0.241 | 0.077 | 0.259 | Tyrosine 3 hydroxylase inhibitor | 0.225 0.097 DBMET00342 0.259 0.06 DBMET00424 0.189 0.156 DBMET00425 0.189 0.156 DBMET00426 0.241 0.077 DBMET00321 0.204 0.128 DBMET00427 | DBMET00424 | |
| 0.245 | 0.087 | 0.4 | Antioxidant | 0.197 0.116 DBMET00342 0.244 0.087 DBMET00424 0.348 0.047 DBMET00425 0.348 0.047 DBMET00426 0.245 0.087 DBMET00321 0.4 0.035 DBMET00427 0.346 0.047 DBMET00428 0.346 0.047 DBMET00429 | DBMET00427 | |
| 0.259 | 0.105 | 0.325 | Caspase 3 stimulant | 0.237 0.124 DBMET00342 0.206 0.16 DBMET00424 0.268 0.098 DBMET00425 0.268 0.098 DBMET00426 0.259 0.105 DBMET00321 0.293 0.082 DBMET00427 0.325 0.068 DBMET00428 0.325 0.068 DBMET00429 | DBMET00429 | |
| 0.26 | 0.12 | 0.41 | Vasodilator, peripheral | 0.215 0.159 DBMET00425 0.215 0.159 DBMET00426 0.26 0.12 DBMET00321 0.303 0.095 DBMET00427 0.41 0.052 DBMET00428 0.41 0.052 DBMET00429 | DBMET00429 | |
| 0.192 | 0.061 | 0.192 | Lipocortins synthesis antagonist | 0.176 0.074 DBMET00342 0.181 0.07 DBMET00424 0.155 0.098 DBMET00425 0.155 0.098 DBMET00426 0.192 0.061 DBMET00321 0.17 0.08 DBMET00427 0.167 0.084 DBMET00428 0.167 0.084 DBMET00429 | ||
| 0.125 | 0.007 | 0.125 | CC chemokine 5 receptor agonist | 0.081 0.062 DBMET00342 0.11 0.013 DBMET00424 0.078 0.072 DBMET00425 0.078 0.072 DBMET00426 0.125 0.007 DBMET00321 0.12 0.008 DBMET00427 0.088 0.042 DBMET00428 0.088 0.042 DBMET00429 | ||
| 0.114 | 0.004 | 0.115 | Nociceptin (N/OFQ) receptor agonist | 0.065 0.005 DBMET00342 0.101 0.004 DBMET00424 0.067 0.005 DBMET00425 0.067 0.005 DBMET00426 0.114 0.004 DBMET00321 0.115 0.004 DBMET00427 0.086 0.004 DBMET00428 0.086 0.004 DBMET00429 | DBMET00427 | |
| 0.136 | 0.028 | 0.153 | Prolactin inhibitor | 0.086 0.072 DBMET00342 0.115 0.042 DBMET00424 0.099 0.056 DBMET00425 0.099 0.056 DBMET00426 0.136 0.028 DBMET00321 0.153 0.021 DBMET00427 0.118 0.039 DBMET00428 0.118 0.039 DBMET00429 | DBMET00427 | |
| 0.098 | 0.005 | 0.1 | Prolactin release inhibitor | 0.074 0.017 DBMET00342 0.077 0.014 DBMET00424 0.076 0.015 DBMET00425 0.076 0.015 DBMET00426 0.098 0.005 DBMET00321 0.1 0.004 DBMET00427 0.095 0.005 DBMET00428 0.095 0.005 DBMET00429 | DBMET00427 | |
| 0.124 | 0.038 | 0.125 | Creatine kinase inhibitor | 0.114 0.045 DBMET00424 0.124 0.038 DBMET00321 0.125 0.037 DBMET00427 | DBMET00427 | |
| 0.187 | 0.109 | 0.329 | Free radical scavenger | 0.199 0.098 DBMET00424 0.272 0.06 DBMET00425 0.272 0.06 DBMET00426 0.187 0.109 DBMET00321 0.329 0.044 DBMET00427 0.257 0.066 DBMET00428 0.257 0.066 DBMET00429 | DBMET00427 | |
| 0.115 | 0.038 | 0.115 | Estrogen receptor beta antagonist | 0.106 0.053 DBMET00342 0.115 0.039 DBMET00424 0.094 0.076 DBMET00425 0.094 0.076 DBMET00426 0.115 0.038 DBMET00321 0.105 0.054 DBMET00427 0.096 0.073 DBMET00428 0.096 0.073 DBMET00429 | ||
| 0.141 | 0.069 | 0.145 | Ca2+-transporting ATPase inhibitor | 0.134 0.1 DBMET00424 0.129 0.128 DBMET00425 0.129 0.128 DBMET00426 0.141 0.069 DBMET00321 0.145 0.056 DBMET00427 0.136 0.091 DBMET00428 0.136 0.091 DBMET00429 | DBMET00427 | |
| 0.099 | 0.028 | 0.099 | Dopamine agonist | 0.099 0.028 DBMET00321 0.093 0.03 DBMET00427 0.072 0.042 DBMET00428 0.072 0.042 DBMET00429 | ||
| 0.122 | 0.051 | 0.126 | Estrogen antagonist | 0.117 0.061 DBMET00342 0.126 0.044 DBMET00424 0.111 0.074 DBMET00425 0.111 0.074 DBMET00426 0.122 0.051 DBMET00321 0.116 0.063 DBMET00427 0.106 0.084 DBMET00428 0.106 0.084 DBMET00429 | DBMET00424 | |
| 0.071 | 0.015 | 0.071 | Dopamine D5 antagonist | 0.043 0.03 DBMET00424 0.071 0.015 DBMET00321 0.065 0.017 DBMET00427 0.053 0.024 DBMET00428 0.053 0.024 DBMET00429 | ||
| 0.145 | 0.091 | 0.197 | Growth hormone agonist | 0.133 0.103 DBMET00342 0.15 0.087 DBMET00424 0.178 0.068 DBMET00425 0.178 0.068 DBMET00426 0.145 0.091 DBMET00321 0.197 0.06 DBMET00427 0.173 0.071 DBMET00428 0.173 0.071 DBMET00429 | DBMET00427 | |
| 0.112 | 0.058 | 0.116 | Electron transport complex I inhibitor | 0.115 0.054 DBMET00342 0.101 0.08 DBMET00424 0.106 0.069 DBMET00425 0.106 0.069 DBMET00426 0.112 0.058 DBMET00321 0.103 0.075 DBMET00427 0.116 0.052 DBMET00428 0.116 0.052 DBMET00429 | DBMET00429 | |
| 0.067 | 0.018 | 0.067 | Dopamine D2 agonist | 0.067 0.018 DBMET00321 0.06 0.021 DBMET00427 0.044 0.031 DBMET00428 0.044 0.031 DBMET00429 | ||
| 0.143 | 0.1 | 0.171 | Interleukin 6 antagonist | 0.131 0.124 DBMET00424 0.153 0.084 DBMET00425 0.153 0.084 DBMET00426 0.143 0.1 DBMET00321 0.171 0.063 DBMET00427 0.165 0.069 DBMET00428 0.165 0.069 DBMET00429 | DBMET00427 | |
| 0.138 | 0.1 | 0.167 | Melanin inhibitor | 0.152 0.079 DBMET00342 0.167 0.062 DBMET00424 0.151 0.08 DBMET00425 0.151 0.08 DBMET00426 0.138 0.1 DBMET00321 0.138 0.1 DBMET00427 | DBMET00424 | |
| 0.051 | 0.019 | 0.051 | Estrogen receptor beta agonist | 0.051 0.019 DBMET00424 0.051 0.019 DBMET00321 0.034 0.023 DBMET00427 | ||
| 0.069 | 0.04 | 0.069 | Dopamine D1 antagonist | 0.069 0.04 DBMET00321 0.059 0.051 DBMET00427 | ||
| 0.129 | 0.1 | 0.129 | NOS3 expression enhancer | 0.129 0.1 DBMET00321 0.129 0.098 DBMET00427 | ||
| 0.196 | 0.169 | 0.222 | Immunomodulator | 0.196 0.169 DBMET00321 0.222 0.14 DBMET00427 0.201 0.163 DBMET00428 0.201 0.163 DBMET00429 | DBMET00427 | |
| 0.032 | 0.008 | 0.034 | Dopamine D1 agonist | 0.024 0.014 DBMET00342 0.034 0.007 DBMET00424 0.023 0.016 DBMET00425 0.023 0.016 DBMET00426 0.032 0.008 DBMET00321 0.031 0.008 DBMET00427 0.022 0.017 DBMET00428 0.022 0.017 DBMET00429 | DBMET00424 | |
| 0.074 | 0.053 | 0.139 | Alpha 2a adrenoreceptor antagonist | 0.071 0.057 DBMET00424 0.1 0.036 DBMET00425 0.1 0.036 DBMET00426 0.074 0.053 DBMET00321 0.139 0.025 DBMET00427 0.105 0.034 DBMET00428 0.105 0.034 DBMET00429 | DBMET00427 | |
| 0.052 | 0.034 | 0.053 | Estrogen agonist | 0.048 0.037 DBMET00424 0.052 0.034 DBMET00321 0.053 0.034 DBMET00427 | DBMET00427 | |
| 0.08 | 0.066 | 0.176 | Alpha 2 adrenoreceptor antagonist | 0.136 0.031 DBMET00425 0.136 0.031 DBMET00426 0.08 0.066 DBMET00321 0.158 0.025 DBMET00427 0.176 0.022 DBMET00428 0.176 0.022 DBMET00429 | DBMET00429 | |
| 0.071 | 0.059 | 0.094 | Na+ K+ transporting ATPase inhibitor | 0.071 0.059 DBMET00342 0.094 0.037 DBMET00424 0.083 0.048 DBMET00425 0.083 0.048 DBMET00426 0.071 0.059 DBMET00321 0.083 0.048 DBMET00427 | DBMET00424 | |
| 0.074 | 0.063 | 0.086 | Acetylcholine nicotinic antagonist | 0.074 0.063 DBMET00321 0.086 0.049 DBMET00427 0.08 0.054 DBMET00428 0.08 0.054 DBMET00429 | DBMET00427 | |
| 0.073 | 0.063 | 0.108 | Antineoplastic antibiotic | 0.071 0.064 DBMET00342 0.076 0.06 DBMET00424 0.104 0.044 DBMET00425 0.104 0.044 DBMET00426 0.073 0.063 DBMET00321 0.108 0.043 DBMET00427 0.1 0.046 DBMET00428 0.1 0.046 DBMET00429 | DBMET00427 | |
| 0.051 | 0.042 | 0.051 | Nicotinic receptor alpha7 subunit antagonist | 0.051 0.042 DBMET00321 0.051 0.041 DBMET00427 0.05 0.044 DBMET00428 0.05 0.044 DBMET00429 | ||
| 0.033 | 0.024 | 0.033 | Estrogen receptor alpha agonist | 0.032 0.025 DBMET00424 0.033 0.024 DBMET00321 0.032 0.025 DBMET00427 | ||
| 0.11 | 0.105 | 0.167 | Lipid peroxidase inhibitor | 0.12 0.094 DBMET00424 0.124 0.089 DBMET00425 0.124 0.089 DBMET00426 0.11 0.105 DBMET00321 0.167 0.057 DBMET00427 0.115 0.099 DBMET00428 0.115 0.099 DBMET00429 | DBMET00427 | |
| 0.086 | 0.086 | 0.212 | Expectorant | 0.101 0.068 DBMET00342 0.185 0.024 DBMET00425 0.185 0.024 DBMET00426 0.159 0.032 DBMET00427 0.212 0.018 DBMET00428 0.212 0.018 DBMET00429 | DBMET00429 | |
| 0.067 | 0.067 | 0.093 | Orexin receptor 1 antagonist | 0.07 0.054 DBMET00425 0.07 0.054 DBMET00426 0.075 0.043 DBMET00427 0.093 0.018 DBMET00428 0.093 0.018 DBMET00429 | DBMET00429 | |
| 0.013 | 0.014 | 0.015 | NMDA receptor phencyclidine site antagonist | 0.015 0.011 DBMET00424 | DBMET00424 | |
| 0.083 | 0.093 | 0.096 | Nav1.1 sodium channel blocker | 0.096 0.072 DBMET00427 0.089 0.083 DBMET00428 0.089 0.083 DBMET00429 | DBMET00427 | |
| 0.246 | 0.259 | 0.34 | Caspase 9 stimulant | 0.275 0.223 DBMET00342 0.328 0.165 DBMET00425 0.328 0.165 DBMET00426 0.299 0.195 DBMET00427 0.34 0.154 DBMET00428 0.34 0.154 DBMET00429 | DBMET00429 | |
| 0.062 | 0.076 | 0.109 | Glycine receptor agonist | 0.067 0.06 DBMET00424 0.109 0.016 DBMET00425 0.109 0.016 DBMET00426 0.109 0.016 DBMET00427 0.098 0.022 DBMET00428 0.098 0.022 DBMET00429 | DBMET00427 | |
| 0.028 | 0.044 | 0.032 | Tubulin agonist | 0.032 0.03 DBMET00427 0.032 0.031 DBMET00428 0.032 0.031 DBMET00429 | DBMET00429 | |
| 0.189 | 0.209 | 0.197 | Interleukin 2 agonist | 0.197 0.194 DBMET00427 | DBMET00427 | |
| 0.064 | 0.088 | 0.098 | Glycine receptor antagonist | 0.088 0.045 DBMET00425 0.088 0.045 DBMET00426 0.098 0.034 DBMET00427 0.082 0.054 DBMET00428 0.082 0.054 DBMET00429 | DBMET00427 | |
| 0.15 | 0.18 | 0.255 | Hypoglycemic | 0.169 0.149 DBMET00425 0.169 0.149 DBMET00426 0.255 0.074 DBMET00427 0.212 0.102 DBMET00428 0.212 0.102 DBMET00429 | DBMET00427 | |
| 0.238 | 0.28 | 0.352 | Antiinflammatory | 0.316 0.201 DBMET00425 0.316 0.201 DBMET00426 0.352 0.171 DBMET00427 0.342 0.178 DBMET00428 0.342 0.178 DBMET00429 | DBMET00427 | |
| 0.069 | 0.113 | 0.122 | Alpha 2c adrenoreceptor antagonist | 0.094 0.072 DBMET00425 0.094 0.072 DBMET00426 0.122 0.048 DBMET00428 0.122 0.048 DBMET00429 | DBMET00429 | |
| 0.211 | 0.259 | 0.368 | Apoptosis agonist | 0.316 0.161 DBMET00425 0.316 0.161 DBMET00426 0.343 0.143 DBMET00427 0.368 0.13 DBMET00428 0.368 0.13 DBMET00429 | DBMET00429 | |
| 0.029 | 0.079 | 0.041 | Microtubule stabilization | 0.041 0.04 DBMET00425 0.041 0.04 DBMET00426 0.041 0.04 DBMET00427 | DBMET00427 | |
| 0.07 | 0.128 | 0.109 | Adenylate cyclase inhibitor | 0.109 0.076 DBMET00427 | DBMET00427 | |
| 0.17 | 0.23 | 0.274 | Apoptosis antagonist | 0.226 0.151 DBMET00425 0.226 0.151 DBMET00426 0.274 0.105 DBMET00427 0.252 0.126 DBMET00428 0.252 0.126 DBMET00429 | DBMET00427 | |
| 0.03 | 0.094 | 0.055 | Dopamine uptake inhibitor | 0.055 0.044 DBMET00428 0.055 0.044 DBMET00429 | DBMET00429 | |
| 0.045 | 0.11 | 0.079 | Orexin receptor antagonist | 0.079 0.028 DBMET00428 0.079 0.028 DBMET00429 | DBMET00429 | |
| 0.05 | 0.129 | 0.102 | Antiadrenergic | 0.077 0.074 DBMET00425 0.077 0.074 DBMET00426 0.102 0.055 DBMET00428 0.102 0.055 DBMET00429 | DBMET00429 | |
| 0.019 | 0.099 | 0.057 | Dopamine D5 agonist | 0.057 0.013 DBMET00424 | DBMET00424 | |
| 0.045 | 0.126 | 0.072 | Acetylcholine M3 receptor agonist | 0.072 0.068 DBMET00427 0.072 0.07 DBMET00428 0.072 0.07 DBMET00429 | DBMET00429 | |
| 0.068 | 0.163 | 0.101 | Microtubule formation inhibitor | 0.098 0.095 DBMET00425 0.098 0.095 DBMET00426 0.101 0.089 DBMET00428 0.101 0.089 DBMET00429 | DBMET00429 | |
| 0.067 | 0.163 | 0.091 | Alpha 2d adrenoreceptor antagonist | 0.087 0.078 DBMET00342 0.091 0.068 DBMET00425 0.091 0.068 DBMET00426 | DBMET00426 | |
| 0.157 | 0.255 | 0.214 | Sodium/bile acid cotransporter inhibitor | 0.198 0.191 DBMET00425 0.198 0.191 DBMET00426 0.214 0.169 DBMET00427 0.203 0.184 DBMET00428 0.203 0.184 DBMET00429 | DBMET00427 | |
| 0.117 | 0.215 | 0.23 | Vasodilator | 0.185 0.117 DBMET00425 0.185 0.117 DBMET00426 0.216 0.092 DBMET00427 0.23 0.082 DBMET00428 0.23 0.082 DBMET00429 | DBMET00429 | |
| 0.094 | 0.2 | 0.143 | Adenylate cyclase stimulant | 0.137 0.086 DBMET00424 0.143 0.076 DBMET00425 0.143 0.076 DBMET00426 0.123 0.118 DBMET00427 | DBMET00426 | |
| 0.135 | 0.243 | 0.179 | Peptidyltransferase inhibitor | 0.179 0.13 DBMET00427 | DBMET00427 | |
| 0.101 | 0.217 | 0.195 | Immunostimulant | 0.16 0.147 DBMET00425 0.16 0.147 DBMET00426 0.195 0.123 DBMET00427 | DBMET00427 | |
| 0.037 | 0.159 | 0.088 | Alpha adrenoreceptor antagonist | 0.088 0.065 DBMET00428 0.088 0.065 DBMET00429 | DBMET00429 | |
| 0.147 | 0.292 | 0.222 | Histamine release inhibitor | 0.222 0.179 DBMET00428 0.222 0.179 DBMET00429 | DBMET00429 | |
| 0.05 | 0.212 | 0.137 | DNA polymerase I inhibitor | 0.121 0.067 DBMET00425 0.121 0.067 DBMET00426 0.137 0.057 DBMET00427 0.119 0.069 DBMET00428 0.119 0.069 DBMET00429 | DBMET00427 | |
| 0.145 | 0.317 | 0.264 | Calcium channel activator | 0.206 0.204 DBMET00342 0.264 0.13 DBMET00425 0.264 0.13 DBMET00426 0.24 0.159 DBMET00428 0.24 0.159 DBMET00429 | DBMET00426 | |
| 0.114 | 0.295 | 0.192 | Cholesterol antagonist | 0.192 0.172 DBMET00427 | DBMET00427 | |
| 0.024 | 0.283 | 0.108 | M18 aspartyl aminopeptidase inhibitor | 0.108 0.082 DBMET00427 | DBMET00427 | |
| 0.041 | 0.421 | 0.14 | Antimitotic | 0.14 0.133 DBMET00428 0.14 0.133 DBMET00429 | DBMET00429 | |
| 0.021 | 0.41 | 0.097 | Bronchodilator | 0.086 0.079 DBMET00425 0.086 0.079 DBMET00426 0.097 0.068 DBMET00428 0.097 0.068 DBMET00429 | DBMET00429 | |
| 0.025 | 0.627 | 0.165 | Tumour necrosis factor alpha release inhibitor | 0.165 0.139 DBMET00428 0.165 0.139 DBMET00429 | DBMET00429 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |